Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,643 | -30,940 | -10,221 | -68,002 | -53,045 |
| Depreciation Amortization | 6,957 | 4,640 | 2,278 | 12,308 | 9,925 |
| Income taxes - deferred | -88 | 5 | 5 | -62 | 36 |
| Accounts receivable | -1,666 | -1,874 | 65 | 15,351 | 9,437 |
| Accounts payable and accrued liabilities | -1,139 | -766 | -1,956 | -8,425 | -3,380 |
| Other Working Capital | -896 | 594 | -2,639 | 1,467 | -3,769 |
| Other Operating Activity | 36,261 | 30,325 | 7,993 | 34,865 | 25,987 |
| Operating Cash Flow | $6,786 | $1,984 | $-4,475 | $-12,498 | $-14,809 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,465 | -1,351 | -356 | -6,381 | -5,400 |
| Net Acquisitions | -13,039 | -13,039 | N/A | N/A | N/A |
| Purchase Of Investment | -16,014 | -10,712 | -6,374 | -27,095 | -22,688 |
| Sale Of Investment | 18,209 | 13,040 | 6,973 | 56,169 | 45,421 |
| Other Investing Activity | -2,028 | -1,594 | -464 | -4,856 | -3,453 |
| Investing Cash Flow | $-15,337 | $-13,656 | $-221 | $17,837 | $13,880 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,182 | -468 | -241 | -498 | -683 |
| Common Stock Issued | 137 | 91 | N/A | 10,751 | 370 |
| Other Financing Activity | 348 | -1,279 | -711 | 338 | 1,063 |
| Financing Cash Flow | $-2,697 | $-1,656 | $-952 | $10,591 | $750 |
| Exchange Rate Effect | -29 | -65 | -65 | 35 | -28 |
| Beginning Cash Position | 35,438 | 35,438 | 35,438 | 19,473 | 19,473 |
| End Cash Position | 24,161 | 22,045 | 29,725 | 35,438 | 19,266 |
| Net Cash Flow | $-11,277 | $-13,393 | $-5,713 | $15,965 | $-207 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,786 | 1,984 | -4,475 | -12,498 | -14,809 |
| Capital Expenditure | -2,465 | -1,351 | -356 | -6,381 | -5,400 |
| Free Cash Flow | 4,321 | 633 | -4,831 | -18,879 | -20,209 |